San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Genomatica is raising $119,117,810.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Christophe Schilling played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Genomatica
Genomatica is a widely-recognized technology leader for the chemical industry. We develop manufacturing processes that enable our licensee partners to produce the worlds most widely-used chemicals a better way, from alternative feedstocks, with better economics and greater sustainability than petroleum-based processes. Genomatica has delivered the industrys first commercial biobased process for a high-volume intermediate chemical. Our GENO BDO process has produced thousands of tons of BDO and been licensed by BASF and Novamont. Multiple large chemical firms have publicly validated quality or described commercialization plans, including Invista (for its well-known Lycra spandex), DSM, Lanxess, Toray, and Far Eastern New Century. Our biotechnology platform and over 500 patents and applications enable us to develop processes for additional major chemicals. The next is for butadiene, with Versalis and Braskem as partners, and over $100 million in industry support. We have also announced our program for nylon intermediates, including HMD, caprolactam and adipic acid. Weve been honored to receive extensive recognition for our innovation, commercialization track record, and potential for broad impact. Recent examples include the Kirkpatrick Award, for the most noteworthy chemical engineering technology commercialized in the world, and the 2015 World Economic Forum Technology Pioneer award.

To learn more about Genomatica, visit http://www.genomatica.com/

Contact:
Christophe Schilling, Chief Executive Officer
858-824-1771
cschilling@genomatica.com
https://www.linkedin.com/in/christophe-schilling-b6947a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved